Mechanical ventilators market seen reaching $9.52 billion by 2035

The global mechanical ventilators market is projected to grow from $5.98 billion in 2026 to $9.52 billion by 2035, driven by aging populations, longer ICU stays and wider use of AI-enabled ventilation systems. Policy changes in the U.S., India and China are also expanding hospital and home-care demand.

Why it matters: - Mechanical ventilators are moving from a crisis-only hospital device to a broader care platform spanning ICUs, home care and transport settings. - Demand is being shaped by demographics, reimbursement policy and automation, not just short-term healthcare spending. - Market Research Future projects the global market will rise from $5.98 billion in 2026 to $9.52 billion by 2035, from a $5.70 billion base in 2025.

What happened: - Market Research Future said the mechanical ventilators market is expected to grow at a 5.3% CAGR from 2026 to 2035. - The forecast is tied to aging populations, prolonged ICU stays and wider adoption of AI-enabled closed-loop ventilation systems. - The report also highlighted policy support in the U.S., India and China that is expanding procurement and access.

The details: - The WHO estimates more than 500 million people globally live with chronic obstructive pulmonary disease, a driver of critical-care admissions. - CMS expanded home ventilation therapy coverage in 2024, creating an estimated $1.2 billion in addressable spending over five years. - India’s National Health Mission allocated INR 64,000 crore, or about $7.6 billion, for hospital infrastructure modernization through 2028, including ICU ventilator procurement. - China’s 14th Five-Year Plan for healthcare targets 120,000 additional ICU beds by 2027 in tier-2 and tier-3 cities. - Updated CMS guidelines effective January 2025 broadened Medicare Part B coverage for home non-invasive ventilation for patients with chronic respiratory failure linked to neuromuscular disease, obesity hypoventilation syndrome and severe COPD. - The policy removed prior-authorization barriers for an estimated 320,000 eligible beneficiaries in the first year. - CMS’s Acute Hospital Care at Home initiative had approved 366 hospitals across 139 health systems by early 2026, with waivers extended through September 2030. - Group purchasing organizations typically cut per-unit ventilator prices by 15% to 25% in high-volume tiers. - A single high-acuity ICU ventilator with full monitoring integration carries a list price of $25,000 to $50,000.

Between the lines: - The market is shifting toward smarter, software-driven systems that can reduce median ventilation duration by 1.5 days and lower reintubation rates by 22% in clinical trials. - That performance is pushing hospitals toward multi-modal devices with real-time patient-ventilator synchrony analysis, automated weaning and cloud-based remote monitoring. - The pricing pressure from GPOs suggests manufacturers may need to lean more on software, service contracts and upgrades to protect margins. - The report’s outlook implies that reimbursement and labor shortages are as important as clinical demand in deciding where ventilators get bought and deployed.

What's next: - The report expects 55% of new ICU ventilator installations globally to include closed-loop automation by 2030. - Manufacturers are likely to keep targeting home ventilation, portable systems and AI-enabled ICU platforms as the fastest-growing segments. - Hospitals and buyers will likely continue weighing software upgrade commitments and multi-year service coverage alongside hardware specs.

The bottom line: - Mechanical ventilators are evolving into a growth market powered by aging patients, policy expansion and automation, with the biggest gains likely in connected ICU and home-care systems. - Segment snapshots from the report point to intensive care ventilators as the largest mobility category, invasive ventilation as the leading interface, adults as the biggest patient group and hospitals as the largest end user. - The report also names North America as the largest regional market, Asia-Pacific as the fastest-growing, and Medtronic, Philips, Dräger and Hamilton Medical among the key competitors.